Metastasis of Lung Cancer to the Oral and Maxillofacial Region: A Case Report and Review of the Literature

Document Type : Case Reports

Authors

1 Columbia University College of Dental Medicine, New York, NY

2 The Metrohealth System, Cleveland, OH

3 Columbia University Irving Medical Center, New York, NY

Abstract

Lung cancer is the most frequent cause of cancer-related deaths in the world. While metastases of
lung malignancies to the oral cavity are rare, lung cancer is the most common malignant neoplasm to metastasize to the head and neck region. Diagnosis of a metastatic lesion in the oral cavity is challenging for clinicians and pathologists alike, but is critical in improving patient outcomes. In our current report, we present a case of a 75 year old female. The patient received a diagnosis of lung adenocarcinoma metastatic to posterior left mandible. The lesion was initially thought to represent a periapical pathology associated with an endodontically involved tooth and has received root canal therapy without resolution of symptoms. We conducted a literature review of cases of lung cancer metastasis to the oral and maxillofacial region published between 2015 and 2022 and compared our findings with existing literature. Malignant non-endodontic lesions can present similarly to many benign lesions in the oral cavity, and early detection and biopsy of these lesions is critical to improving the prognosis of these cases.

Keywords


Introduction

Metastatic tumors to the oral region are uncommon (representing 1-2% of oral malignancies) and may occur in the oral soft tissues or in the jawbones.1  Only 5% of all malignancies involve the oral cavity, and one percent of these malignancies are secondary to neoplasms found below the level of the clavicles.2 These oral metastases are often a late-stage manifestation found in the presence of widespread disease and are associated with poor long-term prognosis, yet they are sometimes the first sign of an undiagnosed malignancy.  The rarity and severity of these metastases make the diagnosis and treatment of these tumors challenging for both the clinician and pathologist.1 Herein, we present a case of a 75-year-old woman with poorly differentiated lung carcinoma involving the mandible, which was initially thought to be a lesion of endodontic origin, and a review of literature spanning 2014-2022.

 

Case Report

A 75-year-old female in apparent good health was referred to an oral surgeon by her treating endodontist for evaluation of persistent swelling of the lower left mandible. Mandibular left first molar, believed to be the source of swelling, received root canal treatment twice over the 6 months preceding the oral surgery visit (Figure 1). An accompanying computer tomography (CT) scan demonstrated reactive periostitis in the area.

Clinical examination revealed slight fullness of lower left face, with no appreciable lymphadenopathy, redness, or tenderness. Intraorally, marked expansion of posterior left mandible was noted, although the mucosal surface was intact and did not show ulceration or discoloration. 

Figure 1: Preoperative panoramic radiograph with no readily apparent lesion apical to mandibular left first molar.

 

Based on the clinical presentation, periapical pathology, such as periapical granuloma or radicular cyst, was suspected.  Radiographically, periapical granuloma presents with an opacity at the apex of a nonvital tooth, although early lesions may present with no radiographic evidence.3 Similar to a periapical granuloma, a radicular cyst is associated with an asymptomatic nonvital tooth, with radiographic appearance identical to that of a periapical granuloma.  Radicular cysts are more likely to be present in the anterior maxilla rather than the molar region of the mandible seen in this case.4 A residual radicular cyst was not considered, as this patient’s lesion was not at an extraction site or an area where an odontogenic cyst was removed. Residual cysts typically present in areas that are not properly curetted.5 Although it is not common for the lining of a residual cyst to undergo malignant transformation to squamous cell carcinoma, it should always be included on a differential with a residual radicular cyst when there is history of extraction or surgical removal of a cyst.6

A biopsy was obtained apical to the distal root of mandibular left first molar was planned to determine the cause of persistent swelling. A mucoperiosteal flap was created and reflected on posterior left buccal alveolar ridge, and a bony window was created with a low-speed handpiece and abundant sterile saline irrigation. Lesional tissue was obtained through the osseous window and submitted for histologic examination along with the bony window. Histologic examination revealed a proliferation of cells with nuclear hyperchromasia, enlargement, and pleomorphism against a background of extravasated red blood cells (Figure 2). Immunohistochemical staining demonstrated the positivity of the lesional cells for panCK, CK7, TTF-1, and Napsin A. CK20, S100, CD45, HMB45, CDX2, and GATA3 were negative. This immunohistochemical profile suggested the lung as the primary origin of the present lesion.

 

Figure 2: Proliferation of cells demonstrating nuclear hyperchromasia, enlargement, and pleomorphism (arrows) against a background of extravasated red blood cells (asterisks), 100x (hematoxylin-eosin).

Materials and Methods

A literature search for metastatic lung cancer cases in the oral and maxillofacial region was performed using references from January 2015 through March 2022 in PubMed, Scopus, Web of Science, and the Columbia University Libraries with combinations of the keywords metastatic lung cancer, metastatic lung carcinoma, metastasizing lung cancer, metastasizing lung carcinoma, jaw metastasis, metastasis to oral cavity, metastasis to jawbones, metastasis to oral and maxillofacial region, and metastasis to salivary glands. The selected publications were analyzed using the following factors: type of lung cancer, site of metastasis, treatment received, and outcome/prognosis. The cases were reported as case reports or reviews of the literature.

We present a review of literature on lung cancer metastases to the oral cavity. To the best of our knowledge, this is the first such literature review since the most recent publication in 2014.7 Results of the literature review of lung tumors metastatic to the oral and maxillofacial region are presented in Table 1.7-51  

 

Results

Forty-five articles were used to identify forty-six cases.  All of the publications entered into the final review were case reports (N=46). 

Patient age was reported in forty-five of the cases.  Most metastatic tumors to the oral and maxillofacial regions were found in patients in their seventh decade (mean age for male was 62.3 years and 67 years for females). This is slightly older than the data from Hirshberg et. al, which reported the most common decades being the fifth and sixth.1

The sex of the patients was mentioned in all of the publications.  Metastatic lung cancer to the oral and maxillofacial region was more prevalent in males (n=33) than in females (n=13; ratio, 2.54:1). This is similar to the 2.5:1 ratio cited for soft tissue metastases.1

In line with past research, the jawbones and hard palate were more affected than the oral soft tissues (25:21), and of the bony structures in the oral and maxillofacial region, the mandible was the most frequently affected structure.  The mandible was the site of oral metastasis nineteen times (n=19) of the forty-six cases.  The posterior mandible or ramus of the mandible was particularly common.

When looking at the oral soft tissues, the attached gingiva of the maxilla was the most commonly affected site (6 cases, 28.5%), followed by the parotid gland (5 cases, 23.8%), and the tongue (4 cases, 19.0%).  The remaining soft tissue sites occurred much less frequently. 

Patients often presented with several symptoms common to past research, the most common being pain, swelling, and paresthesia.  In the event that soft tissue was involved, it was also common that bleeding or ulceration was present. 

In twenty-five of the forty-six cases, the patient was unaware of any primary cancer at the time of presentation with oral symptoms.  This demonstrates that patients can unknowingly have widespread metastatic cancer and present with symptoms that a dental provider should notice. An occult primary should be considered when a patient presents with symptoms suggestive of metastatic disease or if a lesion persists after dental treatment.  No conclusions  can be drawn regarding the frequency of distant oral metastases presenting the first symptom of metastatic disease due to bias of reporting unusual cases. 

Histological typing was done in forty-four cases.  The most common histological type was by far adenocarcinoma (n=24), followed by small cell or neuroendocrine carcinoma (n=9), mesothelioma (n=5), squamous cell carcinoma (n=5), and non-small cell carcinoma (n=1). 

In twenty-six cases there was some form of tobacco use reported in the patient history (56.5% of cases).  Twenty-four of these cases reported that the patient was either a current or former smoker and in two of the cases the patient used a form of smokeless tobacco.  It should be noted that tobacco could have been used in a greater number of the cases, but tobacco use was not specified in sixteen of the cases. 

In the reported cases chemotherapy was by far the most common treatment modality.  Chemotherapy was used in thirty-one (67.4%) of the cases.  This is to be expected as it is known that oral metastases are often a late-stage manifestation found in the presence of widespread disease.1 Radiation therapy was used in twenty-one cases (45.7%), and surgical excision was used in twelve of the cases (26.0%).  Treatment was not specified in six of the cases, the patient declined any treatment in two of the cases, and one patient was lost to follow up. 

Metastasis of a distant primary malignancy to the oral cavity is associated with poor long-term prognosis.1 Of the reported cases, twenty-two of the patients (47.9%)  had died prior to publication of an associated case report.  The overwhelming majority of the patients who died did so within weeks to months of diagnosis of their oral lesion.  At the time of publication ten cases (21.7%) reported that the patient was still living.  No follow-up information was provided on the patient in fourteen of the cases. 

 

Table 1: 2015 to 2022.Results of the literature search of lung tumors metastatic to the oral and maxillofacial region from

 

Reported Case

Author, Year of Publication

Age/Sex

Tumor Site

Direct Extension/ Metastasis

Histological Type

Treatment of Lung Primary If Known Prior to Oral Metastasis

Treatment Following Discovery of Oral Lesion

Follow-up

​​Known lung primary at time of oral diagnosis?

Smoking/Tobacco History

Abe Et al., 20198

76/M

Hard Palate 

Lung

Adenocarcinoma

CTX

CTX

Expired, 4 months after the first admission 

Yes

40.5 pack year history, alcohol use unspecified

Arslan et al., 20169

59/M

Retromolar Trigone (R)

Lung

Mesothelioma

CTX, RTX

None

Expired, 45 days following diagnosis of oral lesion

Yes

Unspecified

Bisht et al., 201710

32/M

Maxilla (R)

Lung

Adenocarcinoma

---

CTX, RTX

Alive, showed partial response to radiotherapy 

No

Smokeless Tobacco, one or two pouches per day. Unspecified alcohol use

Cui et al., 201911

64/M

Parotid Gland (R)

Lung

Small Cell Carcinoma 

---

Sx, CTX

Alive, treatment and follow up are ongoing following three cycles of chemotherapy

No

Unspecified 

D'Antonio et al., 201612

76/M

Palatine Tonsil (R)

Lung

Small Cell Lung Cancer 

---

CTX

Expired, 14 months following presentation

No

“Former smoker of 30-40 cigarettes a day” Unspecified Alcohol Use

Forooghi et al., 201913

57/M

Maxillary Alveolar Ridge (L)

Lung

Squamous Cell carcinoma

CTX, RTX

Symptomatic treatment

Alive, three months after commencing case evaluation

Yes

“Heavy smoker”, unspecified alcohol use

George et al., 201914

68/M

Mandible (R)

Lung 

Adenocarcinoma

---

Sx, CTX, and RTX

Unspecified

No

“Had a habit of smoking 10-15 cigarettes a day for more the 25 years”

~18 pack years, “occasional alcohol consumption”

Guarda-Nardini et al., 201715

59/F

Condylar Head (R)

Lung

Carcinoma

---

RTX, CTX, Sx

Expired, 13 months after initial diagnosis

No

“Smoked 10 to 15 cigarettes per day” unspecified how many years, unspecified alcohol use

Gultekin et al., 20167

72/M

Mandible (R)

Lung

Adenocarcinoma

RTX

Sx,RTX, CTX

Expired, 6 months after initial diagnosis 

Yes

40 pack year smoking history, Unspecified alcohol use

Hussain et al., 202016

66/F

Mandible (R) 

Lung

Poorly Differentiated Neuroendocrine Carcinoma

---

Palliative Care

Expired, 4 weeks after initial presentation

No

Never smoker and “low alcohol intake” 

Ito et al., 201717

85/M

Maxillary Buccal Gingiva (L) 

Lung

Adenocarcinoma

Supportive Care

RTX

Expired “soon”

Yes

Unspecified

Jeba Et al., 201618

45/M

Anterior Tongue (L)

Lung

Adenocarcinoma

---

CTX

Lost to follow-up

No

Smoker, unspecified pack years, unspecified alcohol use

Johnson and Read-Fuller 202019

66/M

Mandible (L)

Lung

Adenocarcinoma 

---

CTX

Alive, treatment is ongoing as of April 2020

No

30 pack-year smoking history, unspecified alcohol use

Kalaitsidou et al., 201520

69/M

Anterior Mandible

Lung

“high grade neuroendocrine carcinoma with elements of both small and large cell lung carcinoma”

CTX

None

Expired, prior to surgical excision of oral lesion

Yes

Unspecified

Kaur et. al., 202121

47/M

Mandible (L)

Lung

Adenocarcinoma

---

CTX

Expired, following two cycles of chemotherapy

No

30 pack year history, unspecified alcohol use

Kawaharada et al., 202222

79/M

Maxilla (L)

Lung

Adenocarcinoma 

Sx, RTX

Supportive Care, RTX

Expired, 11 months after initial presentation for oral lesion

Yes

Unspecified

Kitadai et al., 201923

64/M

Anterior Maxillary Gingiva

Lung

“Non small cell lung cancer favoring adenocarcinoma”

RTX

CTX

Expired due to aspiration pneumonia followed by acute respiratory distress syndrome

Yes

No smoking history, unspecified alcohol use

Lee et al., 202024

87/F

Submandibular Gland (L)

Lung

Small Cell Neuroendocrine Carcinoma

---

Patient Declined

Expired, three months after diagnosis

No

Unspecified

Lee S-Y et al., 201825

63/M

Tip of Tongue 

Lung

Squamous Cell Carcinoma

---

CTX and Sx

Expired, 8 months after presentation for tongue lesion

No

“Heavy alcohol and tobacco use” unspecified pack years 

Lenouvel et al., 201626

59/M

Parotid (R)

Lung

Adenocarcinoma

---

Unspecified

Expired due to cardiac arrest

No

30 pack year smoking history, unspecified alcohol use

Matsuda et. Al., 201827

83/F

Mandible (R)

Lung

Poorly Differentiated Adenocarcinoma 

---

CTX

Alive, two years after initial hospital visit for oral lesion

No

Nonsmoker, unspecified alcohol use 

McKernon et al., 201728

61/F

Mandible (L)

Lung

Adenocarcinoma

---

Unspecified

Unspecified

No

40 pack year smoking history, Unspecified alcohol use

Mohamed et al., 202129

Unspecified age/F

Dorsal Tongue 

Lung

Mesothelioma

CTX 

Supportive Care

Alive, uninterested in RTX for the tongue lesion at six week F/U

Yes

Unspecified 

Moraes et al., 201730

66/M

Mandible (R)

Lung

Small Cell Lung Cancer 

CTX

CTX

Alive at 4 months follow up. Patient was asymptomatic and the x-ray showed signs of new bone formation. 

Yes

Unspecified 

Nuyen and Tang 201631

59/M

Maxillary Gingiva (L)

Lung

Adenocarcinoma

---

RTX

Unspecified

No

Nonsmoker, unspecified alcohol use 

Oliver et al., 202132

51/F

Mandibular Condyle (R) and Mandibular Ramus (R)

Lung

Adenocarcinoma 

---

Unspecified

Unspecified

No

Unspecified

Pezzuto, et al., 2017 (Case 1) 33

65/M

Mandible (R)

Lung

Squamous Cell Carcinoma 

Sx, CTX

RTX, Hyperthermia Treatment 

Expired a few weeks after treatment

Yes

40 pack year history, unspecified alcohol use

Pezzuto, et al., 2017 (Case 2) 33

65/F

Mandible (R)

Lung

Squamous Cell Carcinoma

CTX

Sx

Expired, 7 days after surgery as a result of bleeding and embolism

Yes

“Pack-years above 40”, unspecified alcohol use

Rajini et al., 201534

62/M

Mandible (R)

Lung

Poorly Differentiated Adenocarcinoma 

---

CTX, RTX

Alive, “response to radiotherapy 

is good”

No 

Unspecified

Rajinikanth et al., 201535

60/M

Mandible (R)

Lung

Metastatic Malignant Tumor

---

CTX, RTX

Unspecified 

No

Unspecified

Rocha et al., 202036

55/M

Parotid Region (R)

Lung

Adenocarcinoma 

RTX, CTX

None

Expired, 1 month following presentation with oral lesion

Yes

“Ex-smoker” pack years unspecified

“ex-alcoholic”

Rovira-Wilde et al., 202037

59/F

Mandible (L)

Lung

Adenocarcinoma

---

Unspecified

Expired, 15 months after initial presentation

No

40 pack year smoking history, Unspecified alcohol use

Schneider et al., 201538

61/F

Mandible (L)

Lung

Large-Cell Neuroendocrine Carcinoma

RTX and CTX

RTX and palliative care

Expired, 3 months following presentation with oral lesion

Yes

80 pack year smoking history, no history of alcohol use

Soputro et al., 202239

79/M

Parotid Gland (L)

Lung

Adenocarcinoma

RTX

Sx

Alive, presented to ED 2 months later with left pleural effusion. Long term pleural drainage catheter was placed.

Yes

60 pack year history, prior occupational asbestos exposure, alcohol use unspecified  

Souron et al., 201640

70/M

Posterior Maxillary Gingiva (L) 

Lung

Large Cell Neuroendocrine Carcinoma

CTX

Unspecified

Unspecified

Yes

60 pack year smoking history, unspecified alcohol use

Steffen et al., 202041

50/M

Mandible (L)

Lung

Adenocarcinoma 

Sx, RTX

Sx, CTX

Unspecified 

Yes

“Former smoker”

Stephen et al., 202042

65/F

Parotid (L)

Lung

Adenocarcinoma

---

Patient Declined

Unspecified

No

Unspecified

Tamgadge et al., 202043

41/M

Maxilla

Lung

Adenocarcinoma

Patient never reported back

---

Lost to follow up

No

Gutkha chewer for 20 years, unspecified alcohol use

Tanaka et al., 202044

66/M

Buccal gingiva of Maxilla (L)

Lung

Malignant Pleural Mesothelioma 

CTX

RTX

Expired, 1 month after presentation with gingival tumor

Yes

Unspecified

Thomas and Blake 202145

40/M

Parotid Region (L)

Lung

Small Cell Carcinoma

---

Unspecified

Unspecified

No

“Chronic Smoking”

Tirkey et al., 201946

50/M

Attached gingiva of Anterior Maxilla

Lung

Large Cell Carcinoma

RTX, Supportive Care

Unspecified 

Unspecified

Yes

Unspecified

Veremis et al., 202047

81/F

Anterior Maxilla (R)

Lung

Mesothelioma

Sx, CTX, RTX

Sx

Expired, 12 days after discharge

Yes

Unspecified

Xie et al., 202048

63/M

Root of Tongue 

Lung

Malignant Pleural Mesothelioma

Unspecified

---

Unspecified

No

Unspecified

Yanagisawa et al., 201749

84/M

Mandible (R)

Lung

Small Cell Lung Cancer

CTX

CTX

Alive, partial remission of symptoms following CTX for oral lesion

Yes

“Heavy smoking history”

Unspecified alcohol use

Yang and Xiong 201750

66/M

Parotid Gland (L)

Lung

Adenocarcinoma

---

Sx, CTX, and RTX

Unspecified

No

“Heavy smoking for 30 years” pack years unspecified, unspecified alcohol use

Zaubitzer et al., 201951

66/F

Palatine Tonsil (R)

Lung

Poorly Differentiated Adenocarcinoma

---

CTX

Alive, last MRI correlated with stable disease.  

No

Former smoker with 40 pack year history, unspecified alcohol use

 

Discussion

Metastasis to the oral cavity may occur at any age, but is most common during the fifth and sixth decades of life. There is an almost equal sex distribution in jawbone metastases, whereas in the oral soft tissues there is a 2:1 male to female ratio. 70% of oral metastases manifest after the primary tumor becomes evident, while the remaining 30% are the first clinical manifestation of tumor spread.1 The most common location for these metastases to the oral cavity is the mandible. This predilection is likely due to sites of bone metastasis concentrating in red marrow, as opposed to the primarily fatty marrow composition of the maxilla.52

Lung cancer is one of the most malignant solid tumors. Almost 1,608,823 cases of lung cancer and 1,378,415 cancer deaths occur worldwide each year.53 Lung cancer is also the most common neoplasm to metastasize to the oral cavity,2 usually via blood vessels.1 The average survival rate for metastatic lung cancer is 4 months to 1 year, with a maximum survival rate of five years.54

Lung cancer may also metastasize to the soft tissues. These metastases can appear as dental or periodontal infections and resemble reactive lesions like pyogenic granuloma, epulis, and peripheral giant cell granuloma, or odontogenic infection.55 For gingival metastases, fast growth, a tendency for bleeding, mechanical disorders due to tumor development, ulceration, and a patient’s clinical condition can all suggest a lesion of malignant nature.56 Common symptoms of oral metastases to the oral cavity include a rapidly progressing lesion with potential pain and paresthesia, a bony swelling with tenderness over the affected area, dysphagia, disfigurement, and bleeding.57,58

Gnathic metastases can be initially misdiagnosed as endodontic lesions, as was the case with our patient. According to recent literature, about 0.65%–4.22% of clinically diagnosed endodontic periapical pathoses receive a nonendodontic histopathologic diagnosis, emphasizing the difficulty and importance of identifying and classifying these lesions, particularly the malignant nonendodontic lesions (MNPLs).59 MNPLs are common in the posterior mandible and are usually radiolucent and unilocular, with tooth mobility or bone resorption. On physical examination, metastatic jaw lesions can develop a bony swelling with tenderness over the affected area, pain, and paresthesia. Jaw metastases do not possess a pathognomonic radiographic appearance, most often presenting as lytic radiolucencies with ill-defined margins.Our case featured swelling of the posterior mandible as the major symptom, with no apparent radiolucency.

 

Conclusion

            The ages, sex, most common locations and symptoms of lung cancer metastases to the mandible in this literature review were all similar to previous research done by Hirshberg et al.1 and others. 54% of the cases in the literature review were unaware of the primary cancer prior to the discovery of the oral lesion, compared to only 30% reported in past research. Malignant nonendodontic lesions can present similarly to many benign lesions in the oral cavity, and early detection and biopsy of these lesions are critical to improving the prognosis of these cases.

Conflict of Interest:

The authors declare no conflict of interest.

 

Source of Funding:

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

 

 

  1. Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity - pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44(8):743-752. doi:10.1016/j.oraloncology.2007.09.012
  2. Zachariades N. Neoplasms metastatic to the mouth, jaws and surrounding tissues. J Craniomaxillofac Surg. 1989;17(6):283-290. doi:10.1016/s1010-5182(89)8009
  3. Márton IJ, Kiss C. Protective and destructive immune reactions in apical periodontitis. Oral Microbiol Immunol. 2000;15(3):139-150. doi:10.1034/j.1399-302x.2000.150301.x
  4. Koseoglu BG, Atalay B, Erdem MA. Odontogenic cysts: a clinical study of 90 cases. J Oral Sci. 2004;46(4):253-257. doi:10.2334/josnusd.46.253
  5. Lee J, Costandi J, Mandel L. The residual radicular cyst. N Y State Dent J. 2014;80(4):38-40.
  6. Tarakji B., Shireen A., Umair A., Azzeghaiby S., AlzoghaibiI., & Hanouneh S. (2014). Malignant Transformation of Radicular Cyst/Residual Cyst: A Review of Literature. Journal of Advances in Medicine and Medical Research, 4(25), 4278-4288. https://doi.org/10.9734/BJMR/2014/9536
  7. Gultekin SE, Senguven B, Isik Gonul I, Okur B, Buettner R. Unusual Presentation of an Adenocarcinoma of the Lung Metastasizing to the Mandible, Including Molecular Analysis and a Review of the Literature. J Oral Maxillofac Surg. 2016;74(10):2007.e1-2007.e20078. doi:10.1016/j.joms.2016.06.004
  8. Abe M, Watanabe K, Shinozaki-Ushiku A, et al. Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review. BMC Cancer. 2019;19(1):52. Published 2019 Jan 11. doi:10.1186/s12885-019-5277-1
  9. Arslan A, Ozcakir-Tomruk C, Deniz E, Akin O. A case report of metastasis of malignant mesothelioma to the retromolar trigone. World J Surg Oncol. 2016;14(1):188. Published 2016 Jul 20. doi:10.1186/s12957-016-0942-1
  10. Bisht N, Singh S, Sarin A, Mulajker D, Gupta S, Mishra PS. Maxillary metastasis from carcinoma lung: an unusual presentation. Asian Journal of Oncology. 2017;03(02):136-138. doi:10.4103/asjo.asjo_16_17 
  11. Cui Y, Cui XY, Wu Y, Yin WZ, Zhu ZP. A case of metastasis of small cell lung cancer to the parotid gland: a case report and literature review. J Int Med Res. 2019;47(11):5824-5830. doi:10.1177/0300060519865645
  12. D'Antonio C, Lombardini A, Onesti CE, et al. A rare case of palatine tonsillar metastasis from small cell lung cancer. Transl Lung Cancer Res. 2016;5(6):709-711. doi:10.21037/tlcr.2016.11.07
  13. Forooghi R, Ranaei M, Bijani F, et al. Huge maxillary metastasis of an aggressive Pancoast tumor -A case report. Caspian J Intern Med. 2019;10(3):351-355. doi:10.22088/cjim.10.3.351
  14. George R, Neralla M, Rajan J, Haque AE, Kumar SP. Metastatic Tumour to the Mandible - A Diagnostic and Management Dilemma. Cureus. 2019;11(7):e5093. Published 2019 Jul 7. doi:10.7759/cureus.5093
  15. Guarda-Nardini L, Stellini E, Di Fiore A, Manfredini D. A Rare Case of Misdiagnosed Silent Lung Cancer with Solitary Metastasis to the Temporomandibular Joint Condyle. J Oral Facial Pain Headache. 2017;31(2):180-185. doi:10.11607/ofph.1672
  16. Hussain I, Maharaj K, Prince S. The "numb chin syndrome": A case report. Int J Surg Case Rep. 2020;67:157-160. doi:10.1016/j.ijscr.2020.02.013
  17. Ito H, Onizawa K, Satoh H. Non-small-cell lung cancer metastasis to the oral cavity: A case report. Mol Clin Oncol. 2017;6(3):422-424. doi:10.3892/mco.2017.1141
  18. Jeba J, Backianathan S, Ishitha G, Singh A. Oral and gastrointestinal symptomatic metastases as initial presentation of lung cancer. BMJ Case Rep. 2016;2016:bcr2016217539. Published 2016 Nov 18. doi:10.1136/bcr-2016-217539
  19. Johnson C, Read-Fuller A. Mandibular metastasis from lung adenocarcinoma as the first sign of occult malignancy. Proc (Bayl Univ Med Cent). 2020;33(2):261-262. Published 2020 Feb 5. doi:10.1080/08998280.2020.1719783
  20. Kalaitsidou IG, Astreidis IT, Kontos KI, et al. Metastatic Tumours to the Oral Cavity: Report of Three Cases. J Oral Maxillofac Res. 2015;6(4):e5. Published 2015 Dec 31. doi:10.5037/jomr.2015.6405
  21. Kaur H, Mishra D, Manchanda S, Bhutia O. Mandibular tumour as the primary manifestation of an occult adenocarcinoma. BMJ Case Rep. 2021;14(1):e239151. Published 2021 Jan 7. doi:10.1136/bcr-2020-239151
  22. Kawaharada M, Maruyama S, Abé T, Hayashi T, Kobayashi T, Tanuma J. Metastasis of pulmonary adenocarcinoma to the oral cavity: A case report and literatures review of the last 30 years. Oral Science International. 2022. doi:10.1002/osi2.1130 
  23. Kitadai R, Okuma Y, Kashima J. Gingival metastasis of ALK rearranged non-small cell lung cancer. Case Reports in Oncology. 2019;12(1):171-177. doi:10.1159/000497481 
  24. Lee DH, Kim JH, Yoon TM, Lee JK, Lim SC. Metastatic small cell neuroendocrine carcinoma of the submandibular gland from the lung: A case report. Medicine (Baltimore). 2020;99(4):e19018. doi:10.1097/MD.0000000000019018
  25. Lee S-Y, Kim MK, Won CS. Lingual metastasis to the tip of the tongue as the first sign of metastatic spread in lung cancer: A case report and review of the literature. Korean Journal of Otorhinolaryngology-Head and Neck Surgery. 2018;61(9):489-491. doi:10.3342/kjorl-hns.2017.00017 
  26. Lenouvel D, Bhagwat P, Warnakulasuriya S. Metastases from the lung presenting as a parotid lump. Br J Oral Maxillofac Surg. 2016;54(1):e10-e12. doi:10.1016/j.bjoms.2015.09.002
  27. Matsuda S, Yoshimura H, Yoshida H, Umeda Y, Imamura Y, Sano K. Mandibular metastasis as the first clinical indication of occult lung adenocarcinoma with multiple metastases: A case report. Medicine (Baltimore). 2018;97(15):e0296. doi:10.1097/MD.0000000000010296
  28. McKernon S, Taylor K, Balmer C. Lung cancer diagnosed by a metastatic lesion in the mandible. New Horizons in Clinical Case Reports. 2017;1:20. doi:10.1016/j.nhccr.2017.06.181 
  29. Mohamed IZB, Idle M, Bates T, Yahya S. Tongue: the unusual site in malignant pleural mesothelioma. BMJ Case Rep. 2021;14(4):e241166. Published 2021 Apr 12. doi:10.1136/bcr-2020-241166
  30. Moraes RM, Alves FA, Carvalho BFDC, Costa FD, Lopes RN, Jaguar GC. Mandible metastasis of small cell lung cancer mimicking a residual cyst. Autops Case Rep. 2017;7(1):37-41. Published 2017 Mar 30. doi:10.4322/acr.2017.003
  31. Nuyen BA, Tang CG. Gingival Metastasis: A Case Report and Literature Review. Perm J. 2016;20(1):71-73. doi:10.7812/TPP/15-057
  32. Oliver C, Mouallem G, Dutot-Philipeau N, Longis J, Piot B, Bertin H. A case report of condyle metastasis and a review of the literature. Journal of Stomatology, Oral and Maxillofacial Surgery. May 2021. doi:10.1016/j.jormas.2021.04.013 
  33. Pezzuto A, Morrone M, Mici E. Unusual jaw metastasis from squamous cell lung cancer in heavy smoker: Two case reports and review of the literature. Medicine (Baltimore). 2017;96(21):e6987. doi:10.1097/MD.0000000000006987
  34. Rajini Kanth M, Ravi Prakash A, Raghavendra Reddy Y, Sonia Bai JK, Ravindra Babu M. Metastasis of lung adenocarcinoma to the gingiva: a rare case report. Iran J Med Sci. 2015;40(3):287-291.
  35. Rajinikanth M, Prakash AR, Swathi TR, Reddy S. Metastasis of lung adenocarcinoma to the jaw bone. J Oral Maxillofac Pathol. 2015;19(3):385-388. doi:10.4103/0973-029X.174624
  36. Rocha BA, Paranaíba LM, Dantas CD, et al. Two rare cases of oral metastasis arising from lung adenocarcinoma and esophageal carcinoma. J Clin Exp Dent. 2020;12(10):e999-e1004. Published 2020 Oct 1. doi:10.4317/jced.57125
  37. Rovira‐Wilde A, McKernon SL, Balmer C. Metastatic lesions in the mandible: A case series and literature review. Oral Surgery. 2020;15(1):51-58. doi:10.1111/ors.12560 
  38. Schneider KM, Martinez AY, Guglielmi M. Large cell neuroendocrine carcinoma: topic review and a unique case of metastasis to the mandible. J Maxillofac Oral Surg. 2015;14(Suppl 1):120-126. doi:10.1007/s12663-012-0362-x
  39. Soputro NA, Asairinachan A, Prasad J. Parotid gland metastasis of lung adenocarcinoma identified on surveillance 18F-FDG PET/CT. BMJ Case Rep. 2022;15(1):e246779. Published 2022 Jan 17. doi:10.1136/bcr-2021-246779
  40. Souron B, Weingertner N, Seigle-Murandi F, et al. Rare oral metastasis from a probable large-cell neuroendocrine carcinoma of the lung. Médecine Buccale Chirurgie Buccale. 2016;22(1):49-54. doi:10.1051/mbcb/2015054 
  41. Steffen C, Doll C, Thieme N, Waluga R, Beck-Broichsitter B. Presentation of cervical metastases and pathological mandibular fracture due to pulmonal adenocarcinoma: A case report. Int J Surg Case Rep. 2020;70:53-55. doi:10.1016/j.ijscr.2020.04.044
  42. Stephen N, Raman A, Kumari S, Dineshbabu S, Gochhait D, Siddaraju N. Intraparotid metastasis from lung adenocarcinoma diagnosed by fnac —report of a rare case. Diagnostic Cytopathology. 2020;48(7):662-665. doi:10.1002/dc.24428 
  43. Tamgadge S, Pereira T, Kale S, Shetty S, Tamgadge A. Lung metastasis, an incidental finding in maxilla - A case report. Indian J Pathol Microbiol. 2020;63(2):273-275. doi:10.4103/IJPM.IJPM_325_19
  44. Tanaka T, Nakamatsu K, Imamura T. Metastasis of malignant pleural mesothelioma to maxillary gingiva: A case report and literature review. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2020;32(2):140-144. doi:10.1016/j.ajoms.2019.10.008 
  45. Thomas S, Bhake A. Cytodiagnosis of unusual metastases in parotid gland. Journal of Oral and Maxillofacial Pathology. 2021;25(1):171. doi:10.4103/jomfp.jomfp_267_20 
  46. Tirkey AS, R, Rajeev R, Thatchani GV, Siva SP. Non-small Cell Lung Cancer Metastasis to the Oral Cavity. Oral & Maxillofacial Pathology Journal. 2019;10(2):103-104. doi:10.5005/jp-journals-10037-1165 
  47. Veremis BM, D.D.S., Glass SH, D.D.S., Ramer N, D.D.S., Reich RF, D.D.S. Metastatic Pleural Mesothelioma to the Oral Cavity: Case Report and a Review of the Literature. N Y State Dent J. 2020;86(2):35-41.
  48. Xie P, Wang W, Yang J. Tongue metastasis was the first sign of malignant pleural mesothelioma detected by PET/CT. Eur J Nucl Med Mol Imaging. 2020;47(9):2218-2219. doi:10.1007/s00259-020-04705-1
  49. Yanagisawa S, Miyauchi E, Ichinose M. Numb Chin Syndrome: An Ominous Sign of Lung Cancer. J Thorac Oncol. 2017;12(8):e114-e116. doi:10.1016/j.jtho.2017.03.014
  50. Yang C, Xiong B: Metachronous, solitary parotid gland metastasis of primary lung adenocarcinoma: a misdiagnosed case report and literature review. International Journal of Clinical and Experimental Medicine. 2017;10(2):3906-3911. 
  51. Zaubitzer L, Rotter N, Aderhold C, et al. Metastasis of pulmonary adenocarcinoma to the palatine tonsil. Mol Clin Oncol. 2019;10(2):231-234. doi:10.3892/mco.2018.1776
  52. Kricun ME. Red-yellow marrow conversion: Its effect on the location of some solitary bone lesions. Skeletal Radiol. 1985;14:10–19. doi: 10.1007/BF00361188.
  53. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview [published online ahead of print, 2021 Apr 5]. Int J Cancer. 2021;10.1002/ijc.33588. doi:10.1002/ijc.33588
  54. López-Jornet P, Garcia G, Camacho-Alonso F. Isolated gingival metastasis from lung carcinoma. N Y State Dent J. 2011;77:27–8. PubMed PMID: 21417163.
  55. Huang ChJ, Chang YL, Yang MY, Hsueh CH, Yu ChT. Lung cancer metastatic to the maxillary gingiva—a case report and literature review. Oral Oncology Extra. 2005;41:118–120. doi: 10.1016/j.ooe.2005.02.007.
  56. Curien R, Moizan H, Gerard E. Gingival metastasis of a bronchogenic adenocarcinoma: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:e25–28. PubMed PMID: 17942337
  57. van der Waal RI, Buter J, van der Waal I. Oral metastases: Report of 24 cases. Br J Oral Maxillofac Surg. 2003;41:3–6. doi: 10.1016/S0266-4356(02)00301-7.
  58. Rajappa S, Loya AC, Rao DR, Rao IS, Surath A, Srihari U. Metastasis to oral cavity- A report of two cases and Review of literature. Indian Journal Of Medical & Paediatric Oncology. 2005;26:43–6
  59. Kosanwat T, Poomsawat S, Kitisubkanchana J. Non-endodontic periapical lesions clinically diagnosed as endodontic periapical lesions: A retrospective study over 15 years. J Clin Exp Dent. 2021;13(6):e586-e593. Published 2021 Jun 1. doi:10.4317/jced.57957